QUIT

5.5605.28%
TS

Thomas Sellig

Independent Director

Mr. Thomas Sellig, also known as Tom, M.B.A., is Member of Advisory Board of Modality.AI, Inc. Mr. Sellig serves as Independent Director of AchieveRx, The Quit Company (formerly known as Achieve Life Sciences, Inc.) since March 29, 2023. He is Chief Executive Officer at Adare Pharmaceuticals, Inc. since January 2022. He had been Director of LabConnect, LLC since August 2019 until 2021 and served as its Chief Executive Officer since August 2019 until 2021. Prior to LabConnect, he served as Chief Commercial Officer PSKW, LLC (doing business as ConnectiveRx) from September 2018 to July 2019. Mr. Sellig served as Senior Vice President of Global Sales at Patheon Holdings Coöperatief U.A. From November 2017 to August 2017 and continued to serve as Senior Vice President of Global Sales at Themo Fisher Scientific Inc. He has executive experience in life sciences, with a focus on CDMO. He served as Global Vice President of Sales and Client Services at Covance. Prior to his work at Covance, from 2007 to 2014, he gained a variety of experience through leadership roles at Ventana Clinical, Digitas Healthcare, Medical Broadcasting Company and Procter and Gamble. Mr. Sellig had a variety of sales and marketing leadership roles at Procter & Gamble Company, a multinational consumer goods company, Wyeth, LLC (formerly American Home Products), a pharmaceutical company and Ascent Pediatrics, Inc., a drug development company. He earned his B.A. in Economics from Vanderbilt University and an MBA from New York University.

Positions